z-logo
open-access-imgOpen Access
The Effects of Statins on Mortality Rates among Bacteremic Patients
Author(s) -
Tihomir Štefanec
Publication year - 2002
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/339763
Subject(s) - medicine , hydroxymethylglutaryl coa reductase inhibitors , intensive care medicine , mortality rate , bacteremia , medline , emergency medicine , statin , antibiotics , microbiology and biotechnology , biology , political science , law
SIR-Liappis et al. [1] noted decreased mortality rates among bacteremic patients who were receiving statins, but they were not able to define the mechanisms by which this reduction in the mortality rate occurred. It has recently been proposed that endothelial apoptosis could be the pivotal event in the pathogenesis of systemic inflammatory response syndrome, sepsis, acute respiratory distress syndrome, and multiple-organ dysfunction syndrome [2]. Endothelial apoptosis is caused by Staphylococcus aureus, lipopolysaccharides, and numerous other factors commonly associated with bacteremia and sepsis, and it can be prevented by the use of statins [2, 3]. Other forms of treatment have a dem-

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom